Non-Invasive Diagnostic System Based on Light for Detecting Early-Stage Oral Cancer and High-Risk Precancerous Lesions-Potential for Dentistry

被引:13
|
作者
Tatehara, Seiko [1 ]
Satomura, Kazuhito [1 ]
机构
[1] Tsurumi Univ, Sch Dent Med, Dept Oral Med & Stomatol, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan
关键词
chemiluminescence; autofluorescence; photodynamic diagnosis (PDD); oral cancer; oral epithelial dysplasia (OED); oral potentially malignancy disorders (OPMDs); protoporphyrin IX; fluorescence; INDUCED PROTOPORPHYRIN-IX; 5-ALA-INDUCED PPIX FLUORESCENCE; 5-AMINOLEVULINIC ACID; MALIGNANT-TRANSFORMATION; EPITHELIAL DYSPLASIA; TOLUIDINE BLUE; PHOTODYNAMIC THERAPY; TOPICAL APPLICATION; CLINICAL-EVALUATION; NEOPLASTIC LESIONS;
D O I
10.3390/cancers12113185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The early detection of oral cancer and oral potentially malignant disorders can facilitate minimum intervention and subsequent improvements in prognosis and quality of life after treatment. Recently, several non-invasive adjunctive fluorescence-based detection systems have improved the accuracy of detection and diagnosis of oral cancer and oral potentially malignant disorders. This article summarizes current knowledge about fluorescence-based diagnostic methods and discusses their benefits and drawbacks from a clinical viewpoint. Oral health promotion and examinations have contributed to the early detection of oral cancer and oral potentially malignant disorders, leading to the adaptation of minimally invasive therapies and subsequent improvements in the prognosis/maintenance of the quality of life after treatments. However, the accurate detection of early-stage oral cancer and oral epithelial dysplasia is particularly difficult for conventional oral examinations because these lesions sometimes resemble benign lesions or healthy oral mucosa tissues. Although oral biopsy has been considered the gold standard for accurate diagnosis, it is deemed invasive for patients. For this reason, most clinicians are looking forward to the development of non-invasive diagnostic technologies to detect and distinguish between cancerous and benign lesions. To date, several non-invasive adjunctive fluorescence-based detection systems have improved the accuracy of the detection and diagnosis of oral mucosal lesions. Autofluorescence-based systems can detect lesions as a loss of autofluorescence through irradiation with blue-violet lights. Photodynamic diagnosis using 5-aminolevulinic acid (ALA-PDD) shows the presence of very early oral cancers and oral epithelial dysplasia as a red fluorescent area. In this article, currently used fluorescence-based diagnostic methods are introduced and discussed from a clinical point of view.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [21] Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)
    Liang, Wenhua
    Zhao, Yue
    Huang, Weizhe
    Gao, Yangbin
    Xu, Weihong
    Tao, Jinsheng
    Yang, Meng
    Li, Lequn
    Ping, Wei
    Shen, Hui
    Fu, Xiangning
    Chen, Zhiwei
    Laird, Peter W.
    Cai, Xuyu
    Fan, Jian-Bing
    He, Jianxing
    THERANOSTICS, 2019, 9 (07): : 2056 - 2070
  • [22] Non-invasive diagnosis of early-stage lung cancer via targeted high-throughput DNA methylation sequencing of circulating tumor DNA (ctDNA)
    Cai, Xuyu
    Gao, Yangbin
    Shen, Hui
    Laird, Peter
    Fan, Jian-bing
    Xu, Weihong
    Liang, Wenhua
    He, Jianxing
    CANCER RESEARCH, 2017, 77
  • [23] Current options and controversies in the treatment of high-risk patients with early-stage non-small-cell lung cancer: a surgeon's perspective
    Crabtree, Traves D.
    LUNG CANCER MANAGEMENT, 2012, 1 (01) : 34 - 46
  • [24] Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer
    Louie, Alexander V.
    Siva, Shankar
    Senan, Suresh
    CANCER, 2016, 122 (02) : 322 - 323
  • [25] Knowing the Bad: Adverse Event-Informed, High-Risk, Early-Stage Non-Small Cell Lung Cancer Treatment Options
    Phillips, Joseph D.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (12) : 1975 - 1976
  • [26] Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients
    Gissi, Davide B.
    Gabusi, Andrea
    Tarsitano, Achille
    Asioli, Sofia
    Rossi, Roberto
    Marchetti, Claudio
    Montebugnoli, Lucio
    Foschini, Maria P.
    Morandi, Luca
    CANCER BIOMARKERS, 2020, 28 (04) : 499 - 510
  • [28] Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
    Kodahl, Annette R.
    Lyng, Maria B.
    Binder, Harald
    Cold, Soren
    Gravgaard, Karina
    Knoop, Ann S.
    Ditzel, Henrik J.
    MOLECULAR ONCOLOGY, 2014, 8 (05): : 874 - 883
  • [29] Identification of Candidate Genes in Early-Stage Invasive Ductal Carcinoma Patients with High-Risk Mortality Using Genes Commonly Involved in Breast Cancer: A Retrospective Study
    Hung, Chih-Chiang
    Huang, Hsin-, I
    Hung, Chao-Ming
    Moi, Sin-Hua
    PUBLIC HEALTH GENOMICS, 2021, : 32 - 41
  • [30] US payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer
    Masud, Salwa F.
    Mark, Noah
    Goss, Thomas
    Malinowski, Doug
    Schnitt, Stuart J.
    Sparano, Joseph A.
    Donovan, Michael J.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 972 - 981